Skip to main content Skip to main content
Not investment advice. Educational platform. See Disclaimer.
NASDAQ: LFCR

Lifecore Biomedical, Inc.

Healthcare | Drug Manufacturers - Specialty & Generic
$4.64 as of 2026-09-05 06:18 UTC
Market Cap$170M
Volume113.4K
EPS (TTM)$-1.27

Lifecore Biomedical, Inc. (NASDAQ: LFCR) is a $170M drug manufacturers - specialty & generic company trading at $4.64. Figures from SEC EDGAR and market feeds; updated 2026-09-05 06:18 UTC.

What Lifecore Biomedical, Inc. does

Lifecore Biomedical is a contract development and manufacturing organization located in Minnesota that specializes in developing and manufacturing complex sterile injectable pharmaceutical products, particularly those containing hyaluronic acid. The company operates three cGMP-certified manufacturing facilities and has developed proprietary fermentation-based processes for producing pharmaceutical-grade hyaluronic acid since the early 1980s.

Summarized from Lifecore Biomedical, Inc.’s SEC filings · Read the filing ↗

Pre-revenue, development-stage company: standard profitability ratios (P/E, EV/EBITDA, ROE) do not apply yet because there are no earnings. Watch cash, cash runway, net loss, R&D spend and share dilution instead.

Key facts

Quote
Price$4.64
Market cap$170M
Volume113.4K shares
Valuation
EPS (TTM)$-1.27
Price/book127.25×
Debt/equity97.63

Revenue, margins & earnings

FY2021: net loss $32M on revenue $101M$101MFY2021FY2022: net loss $117M on revenue $111M$111MFY2022FY2023: net loss $100M on revenue $103M$103MFY2023FY2024 Revenue: $128M — margin split not shown (non-operating gains)$128MFY2024FY2025: net loss $39M on revenue $129M$129MFY2025
  • Net income
  • Taxes & interest
  • Operating expenses
  • Cost of revenue
  • Net loss year
Annual revenue; bands show net, operating, gross margins · Open in Platform →

SEC Filings

SEC EDGAR ↗
Recent Insider Activity (last 90 days)
Source: SEC EDGAR · Filed 2026-06-08
  • 2026-06-08Kiper Christopher SA25,907—
  • 2026-06-05OBUS NELSONA25,907—
  • 2026-06-05Aryeh JasonA25,907—
Sign in to see all transactions →
Recent 8-K Events (parsed from SEC filings)All events →
Source: SEC EDGAR 8-K filings · Interpretation: Oxford Ledge parser · Confidence-filtered ≥ 0.50

Company news

View all →

Questions this page answers

What does Lifecore Biomedical, Inc. do?

Lifecore Biomedical is a contract development and manufacturing organization located in Minnesota that specializes in developing and manufacturing complex sterile injectable pharmaceutical products, particularly those containing hyaluronic acid.

What is LFCR's valuation?

LFCR trades at $4.64, as of 2026-09-05.

When did LFCR last file with the SEC?

Lifecore Biomedical, Inc.'s most recent SEC filing on record is a 10-Q filed 2026-08-05. All filings link to their SEC EDGAR originals above.

Where does this data come from?

SEC EDGAR filings and public market data feeds, fetched 2026-09-05 06:18 UTC. This page is also available as JSON at /api/data?ticker=LFCR and is emitted with FAQPage structured data for machine reading.

For you

Charts, 10-year financials, peer comparison, screening and portfolio tracking for LFCR and 5,000+ tickers.

Create a free account — keep LFCR
For your agent
GET /api/data?ticker=LFCR

This page as JSON via rel="alternate" · REST API docs · MCP server (59 tools) · llms.txt